Drug Discovery Nexus Europe 2020

Drug Discovery Nexus Europe is organized by Procurement Direct Ltd and will be held from May 04 - 05, 2020 at Paris , Ile-de-France, France.

Description:
In the new world of drug discovery, the pharma/biotech industry is looking forward toward new techniques to speed up drug discovery, cut R&D costs, decrease failure rates in drug trials and eventually create better medicines, this unique two day Nexus will provide the scope for opportunities to learn progressed by international scientists & top industry leaders to discuss the latest developments in Drug Discovery and development strategies with day one purely focused on early drug discovery and the second day on Modernization in drug discovery.

Benifits of Attending:
• Enrich topics
• Meet experts & influencers face to face
• Focused Networking
• Information about the valuable insights of industry
• Virtual synchronization
• Pronouncement Authority
• Distinct Contrast
• Position yourself as an expert
• Direct contact with potential clients and costumers
• Get fresh ideas and solutions for your business
• Stay current with trends by learning from powerful speakers
• Observe visual cues from presenters & other attendees
• Gain insight into how new techniques are being utilized for Drug Discovery

Job Functions:
• CMO
• Head, Cancer Biology & Pharmacology
• Dir CAR Program, Research & Discovery
• Chief Scientist, R&D
• Director R&D Management
• Director Biomarker Discovery
• Senior Director Preclinical
• CSO
• Head, Biology & Translational Pharmacology
• Head, Oncology Chemistry
• Dir Discovery Chemistry & Technology
• Head of Molecular & Computational Toxicology
• VP, R&D
• Director DMPK
• Director Pharmacology
• Senior Group Leader Medicinal Chemistry
• VP Preclinical R&D
• VP Chemistry
• Director Preclinical Research
• Director Preclinical Drug Safety
• Head, PTS Discovery Genome Editing

Tracks & Sessions:
• Target Identification and Validation.
• Medicinal Chemistry Ameliorations.
• Next Generation Genomics.
• NAPDD.
• Modernization in Drug Discovery.
• CRISPR Screening.
• FBLD.
• Dynamic Combinatorial Chemistry.
• Cell-Based Phenotypic Discovery.
• GPCRs Based Discovery.
• ADMET Prediction Models.
• Insilico Screening.
• NDD(Network-Driven Drug Discovery).
• Predicting Drug Toxicity using CADD.
• Drug Development using QSP modelling.
• Small molecules Drug Discovery.
• Pre-clinical Profiling.